🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

One-year Outcomes by Index Treatment in Elderly Patients With Acute Cholecystitis

Recruitingn/aAges 70 Years - anyAllInstituto de Investigación Sanitaria y Biomédica …
NCT07006298 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: The GOLDENEYE study is an international, multicenter, prospective observational investigation designed to compare the outcomes of various management strategies for acute cholecystitis in patients aged 70 years and older. This research is driven by the increasing prevalence of gallstones and biliary tract diseases in the elderly, alongside a recognition that the burden of comorbidity in this population may necessitate tailored treatment approaches to optimize outcomes. Patients and Methods: The primary aims of the study are to evaluate the efficacy of different treatments -supportive care, percutaneous gallbladder drainage, early or delayed cholecystectomy, and EUS-guided gallbladder drainage- on patient-centric outcomes, including one-year additional treatment modalities, hospital readmissions, outpatient encounters, quality of life, and survival rates. The study adopts a ro

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients ≥70 years * diagnosed with acute cholecystitis, as per the Tokyo guidelines Exclusion Criteria: * prior episodes of cholecystitis or pancreatitis * terminal illness * concurrent diagnosis of acute pancreatitis, cholangitis, bile duct disease, or digestive malignancy
💊

What it tests

  • Not listed
📍

Where

1 site
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Alicante, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy